Contact: research@protoquiz.com

Statewide

Vermont Department of Health

Under review249 dose entries53 drugs2 documentsVTeffective 2025-01-01100% machine-parsed of 249

An undated version is under review. The figures below are from the current listed document.

Drugs and doses53

A–C Acetaminophen, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Chloride, Calcium Gluconate8

Acetaminophen

IndicationPopulationDoseRouteRepeatStandingSource
Mild to moderate pain adult 1000 mg IV not captured standing pages 54, 56, 244 · source
Mild to moderate pain adult 325–1000 mg PO not captured standing pages 54, 56, 244 · source
Mild to moderate pain peds 15 mg/kg PO not captured standing pages 54, 56, 244 · source
Mild to moderate pain peds 15 mg/kg IV not captured standing pages 54, 56, 244 · source

Adenosine

IndicationPopulationDoseRouteRepeatStandingSource
Narrow-complex tachycardia adult 6 mg IV/IO not captured standing pages 92, 93, 94, 244 · source
Narrow-complex tachycardia peds 0.1 mg/kg IV/IO not captured standing pages 92, 93, 94, 244 · source

Albuterol

IndicationPopulationDoseRouteRepeatStandingSource
Asthma / bronchospasm adult 2–4 puff MDI not captured standing pages 28, 29 · source
Asthma / bronchospasm adult 2.5 mg NEB not captured standing pages 22, 28, 29 · source
Asthma / bronchospasm peds 2–4 puff MDI not captured standing pages 28, 29 · source
Asthma / bronchospasm peds 2.5 mg NEB not captured standing pages 22, 28, 29 · source
Cyanide poisoning adult 2.5 mg NEB not captured standing page 71 · source
Cyanide poisoning peds 2.5 mg NEB not captured standing page 71 · source
Hyperkalemia adult 10–20 mg NEB not captured standing pages 41, 80, 100, 101 · source

Amiodarone

IndicationPopulationDoseRouteRepeatStandingSource
Wide-complex tachycardia adult 150 mg IV/IO not captured standing pages 93, 245 · source
Wide-complex tachycardia peds 5 mg/kg IV/IO not captured standing pages 93, 245 · source
VF / pulseless VT adult 300 mg IV/IO not captured standing pages 83, 87, 245 · source
VF / pulseless VT peds 5 mg/kg IV/IO not captured standing pages 83, 87, 245 · source

Aspirin

IndicationPopulationDoseRouteRepeatStandingSource
ACS / chest pain adult 324 mg PO not captured standing pages 77, 246 · source

Atropine

IndicationPopulationDoseRouteRepeatStandingSource
Bradycardia adult 1 mg IV/IO not captured standing pages 80, 81, 246 · source
Bradycardia peds 0.02 mg/kg IV/IO not captured standing pages 80, 81, 246 · source
Nerve agent exposure adult 2 mg IV/IO not captured standing pages 47, 48, 246 · source
Nerve agent exposure peds 0.05–0.1 mg/kg IV/IO not captured standing pages 47, 48, 246 · source

Calcium Chloride

IndicationPopulationDoseRouteRepeatStandingSource
Bradycardia adult 500–1000 mg IV/IO not captured standing pages 41, 80, 81, 247 · source
Bradycardia peds 20 mg/kg IV/IO not captured standing pages 41, 80, 81, 247 · source
Cardiac arrest adult 1000 mg IV/IO not captured standing pages 84, 87, 247 · source
Cardiac arrest peds 20 mg/kg IV/IO not captured standing pages 84, 87, 247 · source
Hyperkalemia adult 500–1000 mg IV/IO not captured standing pages 41, 247 · source
Hyperkalemia peds 20 mg/kg IV/IO not captured standing pages 41, 247 · source
Other adult 1000 mg IV/IO not captured standing pages 100, 247 · source
Other adult 1000 mg IV/IO not captured standing pages 166, 169, 247 · source
Other peds 1000 mg IV/IO not captured standing pages 166, 169, 247 · source
Other peds 20 mg/kg IV/IO not captured standing pages 100, 247 · source

Calcium Gluconate

IndicationPopulationDoseRouteRepeatStandingSource
Bradycardia adult 2000 mg IV/IO not captured standing pages 80, 81, 247 · source
Bradycardia peds 100 mg/kg IV/IO not captured standing pages 80, 81, 247 · source
Cardiac arrest adult 2000 mg IV/IO not captured standing pages 84, 87, 247 · source
Cardiac arrest peds 100 mg/kg IV/IO not captured standing pages 84, 87, 247 · source
Hyperkalemia adult 2000 mg IV/IO not captured standing pages 41, 247 · source
Hyperkalemia peds 100 mg/kg IV/IO not captured standing pages 41, 247 · source
Other adult 2000 mg IV/IO not captured standing pages 100, 101, 247 · source
Other adult 2000 mg IV/IO not captured standing pages 166, 169, 247 · source
Other peds 100 mg/kg IV/IO not captured standing pages 100, 101, 247 · source
Other peds 2000 mg IV/IO not captured standing pages 166, 169, 247 · source
D–F Dexamethasone, Dextrose, Diazepam, Diltiazem, Diphenhydramine, Dopamine, Droperidol, Epinephrine, Etomidate, Fentanyl10

Dexamethasone

IndicationPopulationDoseRouteRepeatStandingSource
Adrenal crisis adult 10 mg IV/IO/IM not captured standing page 21 · source
Adrenal crisis peds 0.6 mg/kg IV/IO/IM not captured standing page 21 · source
Anaphylaxis peds 0.6 mg/kg IV/IO/IM/PO not captured standing pages 22, 24 · source
Asthma / bronchospasm adult 10 mg IV/IO/IM/PO not captured standing pages 28, 29, 253 · source
Asthma / bronchospasm peds 0.6 mg/kg IV/IO/IM/PO not captured standing pages 28, 29, 253 · source
Croup peds 0.6 mg/kg IV/IO/IM/PO not captured standing pages 29, 30 · source

Dextrose

IndicationPopulationDoseRouteRepeatStandingSource
Hypoglycemia adult 25 g IV not captured standing pages 37, 38, 248 · source
Hypoglycemia peds 5 mL/kg IV not captured standing pages 37, 38, 248 · source

Diazepam

IndicationPopulationDoseRouteRepeatStandingSource
Agitation adult 5 mg IV not captured standing pages 32, 248 · source
Nerve agent exposure adult 10 mg IM not captured standing pages 47, 48, 248 · source
Nerve agent exposure adult 5 mg IV not captured standing pages 47, 48, 248 · source
Nerve agent exposure peds 0.3 mg/kg IV not captured standing pages 47, 48, 248 · source
Other adult 2 mg IV not captured standing pages 42, 248 · source
Other adult 2 mg IV not captured standing pages 58, 248 · source
Other adult 5 mg IV/IO not captured standing pages 80, 248 · source
Other adult 5 mg IV not captured standing pages 114, 248 · source
Other peds 0.1 mg/kg IV not captured standing pages 114, 248 · source
Other peds 0.2 mg/kg IV not captured standing pages 42, 248 · source
Procedural sedation adult 5 mg IV/IO not captured standing pages 92, 94, 248 · source
Procedural sedation peds 0.05 mg/kg IV/IO not captured standing pages 92, 94, 248 · source
Seizure adult 5–10 mg IV not captured standing pages 62, 63, 248 · source
Seizure peds 0.1 mg/kg IV not captured standing pages 62, 63, 248 · source

Diltiazem

IndicationPopulationDoseRouteRepeatStandingSource
Narrow-complex tachycardia adult 0.25 mg/kg IV not captured standing pages 92, 93, 249 · source
Narrow-complex tachycardia adult 5–15 mg IV not captured standing pages 93, 249 · source

Diphenhydramine

IndicationPopulationDoseRouteRepeatStandingSource
Dystonic reaction adult 25–50 mg IV/IM not captured standing pages 46, 58, 60 · source
Dystonic reaction peds 0.5 mg/kg IV/IM not captured standing pages 46, 58, 60 · source
Other adult 25–50 mg IV/IO/IM not captured standing pages 22, 24 · source
Other adult 25–50 mg PO not captured standing pages 22, 24 · source
Other adult 25 mg PO not captured standing page 46 · source
Other peds 1 mg/kg IV/IO/IM not captured standing pages 22, 24 · source
Other peds 1 mg/kg PO not captured standing pages 22, 24 · source
Other peds 12.5–25 mg PO not captured standing page 46 · source

Dopamine

IndicationPopulationDoseRouteRepeatStandingSource
Hypotension / shock adult 5–20 mcg/kg IV/IO not captured standing pages 249, 263 · source

Droperidol

IndicationPopulationDoseRouteRepeatStandingSource
Agitation adult 10 mg IM not captured standing pages 158, 249 · source
Nausea / vomiting adult 0.625–1.25 mg IV not captured standing pages 46, 249 · source
Nausea / vomiting adult 0.625–1.25 mg IM not captured standing pages 46, 249 · source
Other adult 5 mg IV/IM not captured standing pages 158, 249 · source

Epinephrine

IndicationPopulationDoseRouteRepeatStandingSource
Anaphylaxis adult 0.3 mg IM not captured standing pages 22, 24 · source
Anaphylaxis peds 0.15 mg IM not captured standing pages 22, 24 · source
Anaphylaxis peds 0.3 mg IM not captured standing pages 22, 24 · source
Cardiac arrest adult 1 mg IV/IO not captured standing pages 83, 86, 88 · source
Cardiac arrest peds 0.01 mg/kg IV/IO not captured standing pages 83, 86, 88 · source
Cyanide poisoning adult 3 mg NEB not captured standing page 71 · source
Cyanide poisoning peds 3 mg NEB not captured standing page 71 · source
Hypotension / shock peds 0.1–1 mcg/kg IV/IO not captured standing pages 68, 70 · source

Etomidate

IndicationPopulationDoseRouteRepeatStandingSource
RSI induction adult 0.3 mg/kg IV/IO not captured standing pages 176, 251 · source
RSI induction peds 0.3 mg/kg IV/IO not captured standing pages 176, 251 · source

Fentanyl

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 50–100 mcg IV/IO not captured standing pages 135, 137, 141 · source
Other adult 50–100 mcg IV/IO not captured standing page 141 · source
Other peds 1 mcg/kg IV/IO not captured standing pages 135, 137, 141 · source
Other peds 1 mcg/kg IV/IO not captured standing page 141 · source
Mild to moderate pain adult 25–100 mcg IV not captured standing pages 54, 57 · source
Mild to moderate pain adult 50–100 mcg IM/IN not captured standing page 54 · source
Mild to moderate pain peds 1 mcg/kg IV not captured standing pages 54, 57 · source
Procedural sedation adult 25–50 mcg IV not captured standing page 80 · source
G–L Glucagon, Haloperidol, Hydrocortisone, Hydroxocobalamin, Ibuprofen, Ipratropium, Ketamine, Ketorolac, Lidocaine, Lorazepam10

Glucagon

IndicationPopulationDoseRouteRepeatStandingSource
Beta-blocker / calcium-channel-blocker overdose adult 2–5 mg IV/IO not captured standing pages 80, 81, 252 · source
Beta-blocker / calcium-channel-blocker overdose peds 0.5 mg IV/IO not captured standing pages 80, 81, 252 · source
Hypoglycemia adult 1 mg IM not captured standing pages 37, 38, 252 · source
Hypoglycemia peds 0.5–1 mg IM not captured standing pages 37, 38, 252 · source

Haloperidol

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 5 mg IM not captured standing pages 158, 252 · source
Other adult 5 mg IM not captured standing pages 158, 252 · source

Hydrocortisone

IndicationPopulationDoseRouteRepeatStandingSource
Adrenal crisis adult 100 mg IV/IO/IM not captured standing page 21 · source
Adrenal crisis peds 2 mg/kg IV/IO/IM not captured standing page 21 · source
Hypotension / shock adult 100 mg IV/IO/IM not captured standing pages 21, 68, 70 · source
Hypotension / shock peds 2 mg/kg IV/IO/IM not captured standing pages 21, 68, 70 · source

Hydroxocobalamin

IndicationPopulationDoseRouteRepeatStandingSource
Cyanide poisoning adult 5 g IV not captured standing pages 71, 253 · source
Cyanide poisoning peds 70 mg/kg IV not captured standing pages 71, 253 · source

Ibuprofen

IndicationPopulationDoseRouteRepeatStandingSource
Mild to moderate pain adult 600 mg PO not captured standing page 54 · source

Ipratropium

IndicationPopulationDoseRouteRepeatStandingSource
Asthma / bronchospasm adult 0.5 mg NEB not captured standing pages 22, 28, 29 · source
Asthma / bronchospasm peds 0.5 mg NEB not captured standing pages 22, 28, 29 · source

Ketamine

IndicationPopulationDoseRouteRepeatStandingSource
Agitation adult 4 mg/kg IM not captured standing pages 158, 159 · source
Agitation peds 4 mg/kg IM not captured standing pages 158, 159 · source
Head injury / TBI adult 4 mg/kg IM not captured standing page 114 · source
Head injury / TBI peds 4 mg/kg IM not captured standing page 114 · source
Mild to moderate pain adult 0.25 mg/kg IV not captured standing pages 55, 57 · source
Mild to moderate pain adult 0.5 mg/kg IM/IN not captured standing pages 55, 57 · source
Mild to moderate pain peds 0.25 mg/kg IV not captured standing pages 55, 57 · source
Mild to moderate pain peds 0.5 mg/kg IM/IN not captured standing pages 55, 57 · source
RSI induction adult 2 mg/kg IV/IO not captured standing page 176 · source

Ketorolac

IndicationPopulationDoseRouteRepeatStandingSource
Mild to moderate pain adult 15 mg IV not captured standing pages 54, 255 · source
Mild to moderate pain adult 30 mg IM not captured standing pages 54, 255 · source

Lidocaine

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 1–1.5 mg/kg IV not captured standing pages 93, 256 · source
Other adult 20–50 mg IO not captured standing pages 155, 256 · source
Other peds 0.5 mg/kg IO not captured standing pages 155, 256 · source
VF / pulseless VT adult 1–1.5 mg/kg IV/IO not captured standing pages 83, 87, 256 · source
VF / pulseless VT peds 1 mg/kg IV/IO not captured standing pages 83, 87, 256 · source

Lorazepam

IndicationPopulationDoseRouteRepeatStandingSource
Agitation adult 1 mg PO not captured standing page 32 · source
Agitation adult 1 mg IV not captured standing page 32 · source
Agitation adult 2 mg IM not captured standing page 32 · source
Nerve agent exposure adult 1 mg IV not captured standing pages 47, 48, 257 · source
Nerve agent exposure adult 2 mg IM not captured standing pages 47, 48, 257 · source
Nerve agent exposure peds 0.1 mg/kg IV not captured standing pages 47, 48, 257 · source
Nerve agent exposure peds 0.1 mg/kg IM not captured standing pages 47, 48, 257 · source
Other adult 1 mg IV/IO not captured standing page 80 · source
Other adult 1 mg IV not captured standing pages 42, 257 · source
Other adult 1 mg IV not captured standing pages 58, 257 · source
Other adult 2 mg IM not captured standing page 80 · source
Other adult 2 mg IM not captured standing pages 42, 257 · source
Other adult 2 mg IM not captured standing pages 58, 257 · source
Other peds 0.1 mg/kg IV not captured standing pages 42, 257 · source
Other peds 0.1 mg/kg IM not captured standing pages 42, 257 · source
Procedural sedation adult 1 mg IV/IO not captured standing page 258 · source
Procedural sedation adult 2 mg IM not captured standing page 258 · source
RSI induction adult 1–2 mg IV/IO not captured standing pages 137, 257, 258 · source
RSI induction peds 0.1 mg/kg IV/IO not captured standing pages 137, 257, 258 · source
Seizure adult 1–2 mg IV not captured standing pages 62, 63, 258 · source
Seizure peds 0.1 mg/kg IV not captured standing pages 62, 63, 258 · source
M–O Magnesium Sulfate, Methylprednisolone, Metoclopramide, Metoprolol, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Ondansetron, Oral Glucose, Oxymetazoline, Oxytocin13

Magnesium Sulfate

IndicationPopulationDoseRouteRepeatStandingSource
Asthma / bronchospasm adult 2 g IV/IO not captured standing pages 28, 29, 258 · source
Asthma / bronchospasm peds 40 mg/kg IV/IO not captured standing pages 28, 29, 258 · source
Seizure adult 4 g IV/IO not captured standing pages 53, 62, 258 · source
VF / pulseless VT adult 1–2 g IV/IO not captured standing pages 83, 87, 258 · source
VF / pulseless VT peds 25–50 mg/kg IV/IO not captured standing pages 83, 87, 258 · source

Methylprednisolone

IndicationPopulationDoseRouteRepeatStandingSource
Adrenal crisis adult 125 mg IV/IO/IM not captured standing page 21 · source
Adrenal crisis peds 2 mg/kg IV/IO/IM not captured standing page 21 · source
Allergic reaction adult 1 mg/kg IV not captured standing pages 22, 24 · source
Allergic reaction peds 1 mg/kg IV not captured standing pages 22, 24 · source
Asthma / bronchospasm adult 125 mg IV/IO/IM not captured standing pages 28, 29 · source
Asthma / bronchospasm peds 2 mg/kg IV/IO/IM not captured standing pages 28, 29 · source

Metoclopramide

IndicationPopulationDoseRouteRepeatStandingSource
Nausea / vomiting adult 10 mg IM not captured standing pages 46, 258 · source
Nausea / vomiting adult 5–10 mg IV not captured standing pages 46, 258 · source

Metoprolol

IndicationPopulationDoseRouteRepeatStandingSource
Narrow-complex tachycardia adult 5 mg IV not captured standing pages 93, 259 · source

Midazolam

IndicationPopulationDoseRouteRepeatStandingSource
Nerve agent exposure adult 2.5 mg IV/IN not captured standing pages 47, 48, 260 · source
Nerve agent exposure adult 5 mg IM not captured standing pages 47, 48, 260 · source
Nerve agent exposure peds 0.2 mg/kg IV/IN not captured standing pages 47, 48, 260 · source
Nerve agent exposure peds 0.2 mg/kg IM not captured standing pages 47, 48, 260 · source
Other adult 2.5 mg IV/IN not captured standing pages 42, 259, 260 · source
Other adult 2.5 mg IV/IN not captured standing pages 58, 260 · source
Other adult 2.5 mg IV/IN not captured standing pages 114, 260 · source
Other adult 5 mg IM not captured standing pages 42, 259, 260 · source
Other adult 5 mg IM not captured standing pages 58, 260 · source
Other adult 5 mg IM not captured standing pages 114, 260 · source
Other peds 0.1 mg/kg IV/IN not captured standing pages 114, 260 · source
Other peds 0.2 mg/kg IV/IN not captured standing pages 42, 259, 260 · source
Other peds 0.2 mg/kg IM not captured standing pages 42, 259, 260 · source
Other peds 0.2 mg/kg IM not captured standing pages 114, 260 · source
Procedural sedation adult 2.5 mg IV/IO/IN not captured standing page 80 · source
Procedural sedation adult 2.5 mg IV/IO/IN not captured standing pages 92, 94, 260 · source
Procedural sedation adult 5 mg IM not captured standing page 80 · source
Procedural sedation adult 5 mg IM not captured standing pages 92, 94, 260 · source
Procedural sedation peds 0.05 mg/kg IV/IO/IN not captured standing pages 92, 94, 260 · source
Procedural sedation peds 0.05 mg/kg IM not captured standing pages 92, 94, 260 · source
RSI induction adult 2.5–5 mg IV/IO not captured standing pages 137, 259, 260 · source
RSI induction peds 0.1 mg/kg IV/IO not captured standing pages 137, 259, 260 · source
Seizure adult 10 mg IM/IN not captured standing pages 62, 63, 260 · source
Seizure adult 5 mg IV not captured standing pages 62, 63, 260 · source
Seizure peds 0.1 mg/kg IV not captured standing pages 62, 63, 260 · source
Seizure peds 0.2 mg/kg IM/IN not captured standing pages 62, 63, 260 · source

Morphine

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 2–4 mg IV not captured standing pages 80, 81, 261 · source
Other adult 2–5 mg IV/IM not captured standing pages 54, 57, 77 · source
Other peds 0.1 mg/kg IV not captured standing pages 80, 81, 261 · source
Other peds 0.1 mg/kg IV/IM not captured standing pages 54, 57, 77 · source
Mild to moderate pain adult 2–5 mg IV/IM not captured standing pages 54, 55, 57, 261 · source
Mild to moderate pain peds 0.1 mg/kg IV/IM not captured standing pages 54, 55, 57, 261 · source

Naloxone

IndicationPopulationDoseRouteRepeatStandingSource
Opioid overdose adult 0.4–2 mg IV/IO/IM/IN/SQ not captured standing pages 26, 27, 58, 60 · source
Opioid overdose adult 0.4–2 mg IV/IO/IM/SQ not captured standing pages 55, 57 · source
Opioid overdose adult 1 mg IN not captured standing pages 26, 27, 58, 60 · source
Opioid overdose adult 2–4 mg IN not captured standing pages 55, 57 · source
Opioid overdose peds 0.1 mg/kg IV/IO/IM/IN/SQ not captured standing pages 26, 27, 58, 60 · source
Opioid overdose peds 0.1 mg/kg IV/IO/IM/SQ not captured standing pages 55, 57 · source
Opioid overdose peds 0.5 mg IN not captured standing pages 26, 27, 58, 60 · source
Opioid overdose peds 1 mg IN not captured standing pages 27, 60 · source
Opioid overdose peds 2–4 mg IN not captured standing pages 55, 57 · source

Nitroglycerin

IndicationPopulationDoseRouteRepeatStandingSource
ACS / chest pain adult 0.4 mg SL not captured standing pages 77, 262 · source
ACS / chest pain adult 1–2 inch TD not captured standing pages 77, 262 · source
CHF / pulmonary edema adult 0.4 mg SL not captured standing pages 89, 262 · source
CHF / pulmonary edema adult 1–2 inch TD not captured standing pages 89, 262 · source

Norepinephrine

IndicationPopulationDoseRouteRepeatStandingSource
Bradycardia peds 0.1–2 mcg/kg IV/IO not captured standing page 91 · source
Hypotension / shock peds 0.1–2 mcg/kg IV/IO not captured standing pages 68, 70, 263 · source
Other peds 0.1–2 mcg/kg IV/IO not captured standing pages 90, 91, 263 · source
Sepsis adult 1–30 mcg IV/IO not captured standing pages 65, 66, 263 · source
Sepsis peds 0.1–1 mcg/kg IV/IO not captured standing pages 65, 66, 263 · source

Ondansetron

IndicationPopulationDoseRouteRepeatStandingSource
Nausea / vomiting adult 4 mg IV/IM/PO/ODT not captured standing pages 46, 263 · source
Nausea / vomiting peds 0.1 mg/kg IV/IM/PO/ODT not captured standing pages 46, 263 · source

Oral Glucose

IndicationPopulationDoseRouteRepeatStandingSource
Hypoglycemia adult 15–30 g PO not captured standing pages 37, 38 · source
Hypoglycemia peds 15 g PO not captured standing pages 37, 38 · source

Oxymetazoline

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 2 spray IN not captured standing pages 39, 264 · source
Other peds 2 spray IN not captured standing pages 39, 264 · source

Oxytocin

IndicationPopulationDoseRouteRepeatStandingSource
Obstetric hemorrhage adult 10 unit IM not captured standing pages 51, 53, 264 · source
P–R Phenylephrine, Pralidoxime, Procainamide, Prochlorperazine, Proparacaine, Rocuronium6

Phenylephrine

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 2 spray IN not captured standing pages 39, 264 · source
Other peds 2 spray IN not captured standing pages 39, 264 · source

Pralidoxime

IndicationPopulationDoseRouteRepeatStandingSource
Nerve agent exposure adult 1–2 g IV not captured standing pages 47, 48, 265 · source
Nerve agent exposure peds 25–50 mg/kg IV not captured standing pages 47, 48, 265 · source

Procainamide

IndicationPopulationDoseRouteRepeatStandingSource
Wide-complex tachycardia adult 10 mg/kg IV not captured standing pages 93, 265 · source

Prochlorperazine

IndicationPopulationDoseRouteRepeatStandingSource
Nausea / vomiting adult 10 mg IM not captured standing pages 46, 258 · source
Nausea / vomiting adult 5–10 mg IV not captured standing pages 46, 258 · source

Proparacaine

IndicationPopulationDoseRouteRepeatStandingSource
Mild to moderate pain adult 2 drop OPH not captured standing pages 103, 265 · source
Mild to moderate pain peds 2 drop OPH not captured standing pages 103, 265 · source

Rocuronium

IndicationPopulationDoseRouteRepeatStandingSource
RSI induction adult 1 mg/kg IV/IO not captured standing pages 176, 266 · source
RSI induction peds 1 mg/kg IV/IO not captured standing pages 176, 266 · source
S–Z Sodium Bicarbonate, Succinylcholine, Tetracaine, Tranexamic Acid, Vasopressin, Vecuronium6

Sodium Bicarbonate

IndicationPopulationDoseRouteRepeatStandingSource
Cardiac arrest adult 1–2 mEq/kg IV/IO not captured standing pages 84, 87, 266 · source
Cardiac arrest peds 1 mEq/kg IV/IO not captured standing pages 84, 87, 266 · source
Hyperkalemia adult 1 mEq/kg IV/IO not captured standing pages 41, 266 · source
Hyperkalemia peds 1 mEq/kg IV/IO not captured standing pages 41, 266 · source
Other adult 1 mEq/kg IV/IO not captured standing pages 100, 101, 266 · source
Other peds 1 mEq/kg IV/IO not captured standing pages 100, 101, 266 · source
Tricyclic overdose adult 1–2 mEq/kg IV/IO not captured standing pages 58, 60, 266 · source
Tricyclic overdose peds 1–2 mEq/kg IV/IO not captured standing pages 58, 60, 266 · source

Succinylcholine

IndicationPopulationDoseRouteRepeatStandingSource
RSI induction adult 1.5 mg/kg IV/IO not captured standing pages 176, 266 · source
RSI induction peds 1.5 mg/kg IV/IO not captured standing pages 176, 266 · source

Tetracaine

IndicationPopulationDoseRouteRepeatStandingSource
Mild to moderate pain adult 2 drop OPH not captured standing pages 103, 266 · source
Mild to moderate pain peds 2 drop OPH not captured standing pages 103, 266 · source

Tranexamic Acid

IndicationPopulationDoseRouteRepeatStandingSource
Obstetric hemorrhage adult 1 g IV/IO not captured standing pages 53, 267 · source
Trauma / hemorrhage adult 1 g IV/IO not captured standing pages 118, 267 · source

Vasopressin

IndicationPopulationDoseRouteRepeatStandingSource
Cardiac arrest adult 40 unit IV/IO not captured standing page 267 · source
Hypotension / shock adult 0.02–0.1 unit IV not captured standing page 267 · source

Vecuronium

IndicationPopulationDoseRouteRepeatStandingSource
RSI induction adult 0.1 mg/kg IV/IO not captured standing pages 176, 267 · source
RSI induction peds 0.1 mg/kg IV/IO not captured standing pages 176, 267 · source
Cite this

Vermont Department of Health, United States EMS Protocol Census. 249 dose entries, effective 2025-01-01.

https://protoquiz.com/census/agencies/vermont-department-of-health-office-of-emergency-medical-services/

Outdated or wrong? Fix or remove itAll Vermont agenciesMethodologyData licenseStudy these protocols in the app

The census is free and not for sale. Only public agencies are named.

Training reference compiled from published protocols. Not a clinical order. Verify with your agency and medical director.